更新了转移性三阴性乳腺癌的奥地利治疗算法
Rupert Bartsch1, Gabriel Rinnerthaler2, Edgar Petru3
1Department of Medicine I, Division of Oncology, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
Wiener klinische Wochenschrift
|September 8, 2023
概括
三重阴性乳腺癌 (TNBC) 的结果不好. 专家们审查了包括sacituzumab govitecan在内的疗法,以改善转移性TNBC患者的治疗.
科学领域:
- 在瘤学瘤学.
- 医学研究 医学研究
背景情况:
- 三阴性乳腺癌 (TNBC) 占诊断的15%.
- TNBC具有更高的复发和转移风险,特别是在大脑中.
- 与其他亚型相比,TNBC的治疗进展有限.
研究的目的:
- 为可用的转移性TNBC (mTNBC) 疗法建立临床风险益处概况.
- 讨论sacituzumab govitecan在TNBC治疗算法中的潜在作用.
主要方法:
- 专家会议由奥地利乳腺癌专家召开.
- 对现有的mTNBC治疗选择进行全面审查.
- 讨论的重点是临床风险益处评估.
主要成果:
- 摘要不包含专家会议的具体结果.
- 重点是评估当前的治疗方法和sacituzumab govitecan的潜力.
结论:
- 需要改善TNBC的治疗策略.
- 正在考虑Sacituzumab govitecan在mTNBC治疗领域的作用.
相关概念视频
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K